Abstract
A new antibiotic, structurally related to cephaloglycin, has been assigned the generic name cephalexin, 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-5-carboxylic acid. In vitro antimicrobial activity of cephalexin does not equal that of cephaloglycin. However, excellent oral absorption and lack of serum binding of cephalexin compensates significantly for the lower in vitro activity. Exceptional efficacy against experimental bacterial infections in mice was obtained with cephalexin therapy as compared with cephaloglycin, tetracycline, and chloramphenicol. The data suggest that cephalexin merits clinical trial.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BONIECE W. S., WICK W. E., HOLMES D. H., REDMAN C. E. In vitro and in vivo laboratory evaluation of cephalothin, a new broad spectrum antibiotic. J Bacteriol. 1962 Dec;84:1292–1296. doi: 10.1128/jb.84.6.1292-1296.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WICK W. E., BONIECE W. S. IN VITRO AND IN VIVO LABORATORY EVALUATION OF CEPHALOGLYCIN AND CEPHALORIDINE. Appl Microbiol. 1965 Mar;13:248–253. doi: 10.1128/am.13.2.248-253.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]